Skip to content

Search research programmes

Filter results

1-26 of 26 search results

Name Qualification Mode Type

Visual Neuroscience

Visual Neuroscience

PhD Full-time, Part-time Area


The School of Psychology is an excellent environment in which to do research. Research training is a strong feature of our Psychology PhD programme.

PhD, MPhil Full-time, Part-time Programme


The School of Medicine offers research degrees in the medical disciplines such as cancer, immunology, infection, immunity, neurosciences, mental health and population medicine.

PhD, MPhil, MD Full-time, Part-time Programme

Clinical Psychology

The programme is three years full-time and leads to the award of Doctor of Clinical Psychology validated by Cardiff University.

DClinPsy Full-time Programme

Social Sciences

The School of Social Sciences has an exceptionally strong and interdisciplinary research culture, and offers expert supervision across a wide range of research topics.

PhD, MPhil Full-time, Part-time Programme

Educational Psychology

The aim of the programme is to offer knowledge and expertise for a career as an educational psychologist (EP), via doctorate-level study.

DEdPsy Full-time Programme

Vision Sciences

Our PhD in Vision Sciences comprises student-led research across a wide range of disciplines, from molecular and cell biology to neuroscience and clinical studies of human vision.

PhD Full-time, Part-time Programme

Psychological Medicine and Clinical Neurosciences

The Division of Psychological Medicine and Clinical Neurosciences is one of the largest university Division of psychiatry in the UK, providing leadership in clinical practice, teaching and high quality, cutting-edge research across many areas of psychiatric practice.

PhD, MPhil, MD Full-time, Part-time Area

Studying human neuropsychiatric disease in DLG2 deficient human neurons

This PhD project in Medicine tries to understand DLG2’s role during neural development and in mature neurons using variety of techniques.


Integration of genetic and functional data to identify drug targets and enhance risk prediction

Integrating brain expression and protein-protein interaction data with genomic data identified a network of immune-related genes implicated in Alzheimer’s disease (AD) susceptibility.


Characterising DNA damage repair in Huntington’s disease

This is an exciting opportunity to help define the molecular mechanism of Huntington’s disease (HD).


Detecting dysfunction in the single-cell gene networks underlying Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and results from the selective loss of dopaminergic neurons within the Substantia nigra pars compacta.


Microglial NFAT signalling and Alzheimer’s disease genetic risk networks

In this project, you will develop skills in molecular biological, cell culture, genome biology and bioinformatics.


Making the move: Understanding the transition of young people with social care needs from Child and Adolescent Mental Health Services (CAMHS) to adult services

This project focusses on understanding the transition of young people with social care needs from child and adolescent mental health services to adult services.


The molecular basis of cognitive flexibility

This project examines transcriptomes in key brain regions at critical periods to determine the molecular bases of flexible behaviour.


Investigating peroxisome dysregulation in Alzheimer’s disease

In this project you will first determine how peroxisomes respond to the specific pathogenic proteins associated with AD in vivo.


Targeting LAG3+ T cells for Cancer Immunotherapy

This study will look at the control of adaptive immunity in health and inflammation by human blood and mucosal gamma/delta T cells.


Machine Learning for Prediction in Alzheimer's Disease: Identifying Novel Biologically Valid Diagnostic Categories to Inform Precision Medicine

The project will involve investigating the ability of machine learning.


Alzheimer’s disease: Understanding the interaction of microglia risk genes

The aim of this project is to understand the interdependence of specific risk alleles and highlight the possibility of adjunctive therapies targeting different ‘arms’ of the immune cells to treat the disease.


Investigating the childhood neurodevelopmental origins of adult mental illness

This PhD utilises new data generated by a Wellcome Trust Collaborative Award between Cardiff and Bristol Universities to test hypotheses on why child NDDs show links with later adult mental illness.


Flexible vectors for immunotherapy against cancer and pathogens

This project aims to determine pathways that can drive the growth of particular types of NK and T cells that are optimised to provide better protection from disease. We will use cytomegalovirus and leukaemic cells as systems of analysis.


Enhancing immune stimulation for novel anti-cancer viral vaccine vectors

We will combine cutting-edge proteomics with molecular virology and immunology to determine how HCMV induces such strong responses, enabling us to generate optimised vaccine vectors.


Role of a mouse ortholog of CR1 (crry) in the 3xTG model of Alzheimer’s Disease (AD)

In order to explore further roles of Crry, we have generated and established a 3xTG/Crry-/- colony, but have not yet had resources to explore further the impact of Crry deficiency in this model.


Optimizing adult mental health outcomes in children with neurodevelopmental problems: interplay of social and genetic factors

This PhD project provides a unique opportunity to develop advanced methodological and analytic skills in the field of developmental psychopathology.


School experiences in children at high genetic risk of mental health problems

This project will provide important insights into why children with a genomic disorder struggle in school.


Molecular mechanisms of CRISPR Cas9 nickase-induced CAG/CTG repeat contraction: Implications for gene editing in expanded repeat disorders

The aim of this project is to understand how contractions occur at the molecular level such that we can make a potential gene editing-based treatment safer and more efficient.